Abstract:The last decades of biological, toxicological, and pharmacological research have deeply changed the way researchers select the most appropriate 'pre-clinical model'. The absence of relevant animal models for many human diseases, as well as the inaccurate prognosis coming from 'conventional' pre-clinical models, are among the major reasons of the failures observed in clinical trials. This evidence has pushed several research groups to move more often from a classic cellular or animal modeling approach to an alternative and broader vision that includes the involvement of microfluidic-based technologies. The use of microfluidic devices offers several benefits including fast analysis times, high sensitivity and reproducibility, the ability to quantitate multiple chemical species, and the simulation of cellular response mimicking the closest human in vivo milieu. Therefore, they represent a useful way to study drug-organ interactions and related safety and toxicity, and to model organ development and various pathologies 'in a dish'. The present review will address the applicability of microfluidic-based technologies in different systems (2D and 3D). We will focus our attention on applications of microchip electrophoresis (ME) to biological and toxicological studies as well as in drug discovery and development processes. These include high-throughput single-cell gene expression profiling, simultaneous determination of antioxidants and reactive oxygen and nitrogen species, DNA analysis, and sensitive determination of neurotransmitters in biological fluids. We will discuss new data obtained by ME coupled to laser-induced fluorescence (ME-LIF) and electrochemical detection (ME-EC) regarding the production and degradation of nitric oxide, a fundamental signaling molecule regulating virtually every critical cellular function. Finally, the integration of microfluidics with recent innovative technologies-such as organoids, organ-on-chip, and 3D printing-for the design of new in vitro experimental devices will be presented with a specific attention to drug development applications. This 'composite' review highlights the potential impact of 2D and 3D microfluidic systems as a fast, inexpensive, and highly sensitive tool for high-throughput drug screening and preclinical toxicological studies.

High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research

Microengineering Methods for Cell-Based Microarrays and High-Throughput Drug-Screening Applications

A Sandwiched Microarray Platform for Benchtop Cell-Based High Throughput Screening

Advances in high throughput cell culture technologies for therapeutic screening and biological discovery applications

Application of DNA Microarray Technologies in Neurotoxicology Research

Droplet Microarrays in Biomedical High-Throughput Research

The development of high-content screening (HCS) technology and its importance to drug discovery

Protein microarrays for studies of drug mechanisms and biomarker discovery in the era of systems biology.

Microarrays: Technologies and Applications

Microfluidics in High-Throughput Drug Screening: Organ-on-a-Chip and C. elegans-Based Innovations

The latest advances in high content screening in microfluidic devices

Recent Advances on Cell Culture Platforms for In Vitro Drug Screening and Cell Therapies: From Conventional to Microfluidic Strategies

An Image-Based High-Throughput and High-Content Drug Screening Method Based on Microarray and Expansion Microscopy

Recent Progress in Development and Application of DNA, Protein, Peptide, Glycan, Antibody, and Aptamer Microarrays

Microfluidics as a Novel Tool for Biological and Toxicological Assays in Drug Discovery Processes: Focus on Microchip Electrophoresis

Protein Microarrays and Their Medical Applications

High Throughput Scaffold-Based 3D Micro-Tumor Array for Efficient Drug Screening and Chemosensitivity Testing.

Microarray Expression Profiling: Analysis and Applications.

High-Throughput Transcriptome Profiling in Drug and Biomarker Discovery

High-throughput screening of biomolecules using cell-free gene expression systems

Microfluidics for cell-based high throughput screening platforms - A review.